Instil Bio Inc has a consensus price target of $12.14, established from looking at the 22 latest analyst ratings. The last 3 analyst ratings were released from Baird, Jefferies, and HC Wainwright & Co. on May 13, 2024, April 12, 2024, and March 25, 2024. With an average price target of $20.33 between Baird, Jefferies, and HC Wainwright & Co., there's an implied 83.85% upside for Instil Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Instil Bio (NASDAQ: TIL) was reported by Baird on May 13, 2024. The analyst firm set a price target for $32.00 expecting TIL to rise to within 12 months (a possible 189.33% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Instil Bio (NASDAQ: TIL) was provided by Baird, and Instil Bio maintained their outperform rating.
There is no last upgrade for Instil Bio.
The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a maintained with a price target of $54.00 to $32.00. The current price Instil Bio (TIL) is trading at is $11.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.